Filing Details

Accession Number:
0000899243-19-013224
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-13 16:21:12
Reporting Period:
2019-05-09
Accepted Time:
2019-05-13 16:21:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1217234 Caredx Inc. CDNA Services-Medical Laboratories (8071) 943316839
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1702824 Brian Michael Bell C/O Caredx, Inc.
3260 Bayshore Boulevard
Brisbane CA 94005
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-09 833 $1.00 90,623 No 4 M Direct
Common Stock Acquisiton 2019-05-09 139 $2.80 90,762 No 4 M Direct
Common Stock Acquisiton 2019-05-09 937 $5.90 91,699 No 4 M Direct
Common Stock Acquisiton 2019-05-09 292 $6.31 91,991 No 4 M Direct
Common Stock Disposition 2019-05-09 14,894 $32.42 77,097 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2019-05-09 833 $0.00 833 $1.00
Common Stock Employee Stock Option (right to buy) Disposition 2019-05-09 139 $0.00 139 $2.80
Common Stock Employee Stock Option (right to buy) Disposition 2019-05-09 937 $0.00 937 $5.90
Common Stock Employee Stock Option (right to buy) Disposition 2019-05-09 292 $0.00 292 $6.31
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,834 2027-04-21 No 4 M Direct
4,167 2027-09-01 No 4 M Direct
29,063 2027-10-27 No 4 M Direct
9,926 2028-01-19 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.625, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  3. 1/4th of the shares subject to the option vested on April 21, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
  4. 1/2 of the shares subject to the option vested on September 1, 2018 and 1/72nd of the shares subject to the option vest monthly thereafter.
  5. 1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
  6. 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.